Ophthalmology laboratory Nicox has announced its intention to transfer the listing of its shares from the Euronext Paris regulated market to Euronext Growth Paris, and to this end is convening its shareholders to an Ordinary General Meeting (AGM) on Tuesday February 14.

We believe that Euronext Growth is better suited to the company, particularly its size, and would enable us to better focus our resources on our business, while benefiting from a listing on a strong and growing exchange", explains CBO Gavin Spencer.

If shareholders vote in favor of the project, and subject to the approval of Euronext Paris, listing on Euronext Growth Paris will take place within a minimum of two months following the AGM, and up to a maximum of 12 months following this meeting.

Copyright (c) 2023 CercleFinance.com. All rights reserved.